Purpose: HDR 60 Co system has recently been developed and utilized for brachytherapy in many countries outside of the U.S. as an alternative to 192 Ir. In addition, the AccuBoost ® technique has been demonstrated to be a successful non-invasive image-guided breast brachytherapy treatment option. The goal of this project is to evaluate the possibility of utilizing the BEBIG HDR 60 Co system for AccuBoost treatment. These evaluations are performed with Monte Carlo (MC) simulation technique.
afterloader (Eckert & Ziegler BEBIG GmbH, Berlin, Germany) [7, 8, 9, 10, 11, 12, 13, 14, 15] . These afterloaders are utilized in many countries outside of the U.S. Following is a brief description of each of these systems: 1. GZP6 HDR is composed of three different channels and contains six different source tandems [1, 2, 3] . Each source tandem is designated for a specific function through a specific channel in the HDR unit. Five out of the six sources are stationary and one source (source number 6) has stepping capabilities for the treatment of longer active lengths than the other sources. Each source is composed of a source-braid or packing that consists of one to four radioactive 60 Co source pellets. These sources also consist of some non-active steel pellets. Dosimetric characteristics of these sources have been evaluated following the AAPM TG-43 recommendations [16, 17, 18] by different investigators [3, 4, 5] . The treatment planning system (TPS) permits selections of the source arrangements and prescription doses. These plans are not user-adjustable. 2. The Ralstron remote afterloader is used for treatment of patients with gynecological cancers [6] . Three different HDR 60 Co source geometries have been designed that incorporate two 60 Co pellets either in contact or spaced 9 mm and 11 mm apart. The dosimetric data used with this afterloader system has been obtained by Papagiannis et al. using Monte Carlo (MC) dosimetry techniques [6] . These authors present a complete dosimetric dataset with tabulated data in the form of 'along and away' format and following the AAPM TG-43 formalism [16, 17, 18] . 3. The third HDR 60 Co system was introduced by BEBIG using the model Co0.A86 source. This source is composed of a 3.5 mm long and 0.5 mm diameter central cylindrical active core that is made of metallic cobalt, containing 60 Co. The active core is covered by a cylindrical stainless-steel capsule of 0.15 mm thick with a 1 mm external diameter. Dosimetric characteristics of this source design have been evaluated using the MC simulation technique following the TG-43 recommendations [7, 8, 9, 10, 11, 12, 13, 14, 15] . Although dosimetric characteristics of these sources have been evaluated using the TG-43 formalism, their clinical applications have not been fully explored, particularly in the U.S. For example, the AccuBoost technique has been introduced (Advanced Radiation Therapy, LLC, Tyngsboro, MA, USA) [19, 20, 21] for boost or accelerated partial breast irradiation (APBI) treatment modalities [22, 23] using non-invasive image-guided breast brachytherapy (NIBB) [24, 25] in contrast to other interstitial techniques [26, 27, 28, 29] . The clinical advances of this treatment technique have been demonstrated by different investigators [23] . However, application of this treatment modality is currently limited to HDR 192 Ir systems.
The goal of this study was to examine the possibility of APBI treatments with HDR 60 Co sources. This evaluation was performed by calculating dose distributions for both 60 Co and 192 Ir sources in the same breast geometry using MC simulations. Dose distributions were calculated with the standard AccuBoost applicators and also with novel applicators to achieve suitable dosimetric results with HDR 60 Co sources.
Material and methods

Radioactive sources
For these investigations, two commercially-available HDR brachytherapy sources were considered; the microSelectron HDR 192 Ir (model 105.002 "v2" , Nucletron, an Elekta company, Elekta AB, Stockholm, Sweden) [18, 30, 31] , and the BEBIG HDR 60 Co model Co0.A86 source [7, 18] . Selection of these sources was based on scientific examples for each radionuclide, and did not indicate product endorsement by the authors. Details of their design and geometric characteristics are presented below. It should be noted that the comparison of the dose rate constants and air-kerma rate constant of these sources indicate that 1 GBq of 60 Co is equivalent to 2.77 GBq of 192 Ir [18] . Currently, these sources are available with 370 GBq (10 Ci) for 192 Ir, and 74 GBq (2 Ci) for 60 Co (model Co0. A86, Eckert & Ziegler BEBIG) [32] . With the above information, 2 Ci of 60 Co is equivalent to 5.54 Ci of 192 Ir.
High-dose-rate 192 Ir source
The microSelectron 192 Ir source has an active length of 3.6 mm with diameter of 0.65 mm (Figure 1 
High-dose-rate 60 Co source
The BEBIG model Co0.A86 source is shown in Figure 2 . This source contains a 60 Co pellet having a length of 3.5 mm and a diameter of 0.5 mm, which is covered by a 0.15 mm thick cylindrical stainless-steel capsule with an external diameter of 1.0 mm. The TG-43 dosimetry parameters of this source have also been evaluated [7, 8] .
Monte Carlo calculations
Version 1.40 of the MCNP5 MC code was used to perform radiation transport simulations in these investigations [33] . Among the different tally types available in the MCNP code for scoring diverse radiological characteristics [34] , the *F4 tally was used to estimate the brachytherapy dose distributions. This track-length tally provided energy flux in units MeV/cm 2 that was converted to absorbed dose by assuming its equivalence with collisional kerma and applying suitable µ en /ρ coefficients. In these simulations, the sources were positioned within a cubic water phantom 30 cm on each side. The range of knockon electrons was considered small for this study, so only photon transport was conducted. Spherical tally cells with radii ranging from 0.2 mm to 0.7 mm were utilized for scoring dose at different distances. The statistical fluctuations of the calculated values were diminished by increasing the tally cell size with increasing distance. The accuracy of our MC simulation techniques for brachytherapy dosimetry has been previously demonstrated [35, 36] . Figure 3 shows a simplified schematic view of the simulation geometry containing the breast tissue, chest wall, and applicators. All simulations were performed with 10 9 photon histories to ensure that statistical uncertainties in absorbed dose results were < 0.5%.
Phantom and applicator geometries
MC simulations were performed with identical phantom geometries in order to compare the dose distributions delivered by the 60 Co or 192 Ir sources to the breast and the surrounding normal tissues. Figure 3A shows the position of the source within the catheter of a 6 cm diameter applicator [20] . Two applicators were positioned in a parallel-opposed manner, directing beams of collimated radiation towards the compressed breast tissue located between the two applicators. Within each applicator, 18 dwell positions were simulated (Figure 4) , where source-to-source scatter would have a negligible effect on the dose outside the applicators [37] . Three sets of simulations were conducted and are described as follows: 1. The applicator and phantom geometries for the two source types were initially the same: see Figure 3A . 2. Calculated skin dose from the 60 Co source was evaluated, and the applicator wall thickness was increased from 6 mm to 12 mm, see Figure 3B , to reduce the chest wall dose to a comparable value from the 192 Ir source. The heights of the applicator (i.e. distance between the source center and open surface of the applicator) remained the same as the standard applicator from AccuBoost (i.e. 24 mm) [20] . 3. Simulations for the aforementioned applicators were repeated with the presence of a conical attenuator as in Figure 3C . These calculations were performed assuming water as composition of chest phantom, while the breast tissue was composed of hydrogen 9.4%, carbon 61.9%, nitrogen 3.6%, oxygen 24.5%, and calcium 0.6%. A water phantom with dimension of 30 × 30 × 20 cm 3 , was considered for the chest region. Three different compressed breast sizes were also considered in this study, including (12 × 12 × 4 cm 3 ), (12 × 12 × 6 cm 3 ), (12 × 12 × 8 cm 3 ). Therefore, the simulations were performed for compressed breast thicknesses of 4, 6, and 8 cm.
To score dose inside the breast and chest, the phantom was divided to fine cubic (0.5 cm) 3 tally cells (see Figure 3) . In addition to dose distributions within the breast, the chest wall dose and the breast skin dose were assessed. In these simulations, the dwell times and positions of both source types were considered such that the accumulated dose to the center of the breast would be 3,400 cGy. The regions defined for estimating radiation dose to the breast skin and chest wall are shown in Figures 5A and 5B, respectively. As mentioned previously, these regions were subdivided into (0.5 cm) 3 cubic tally cells. Figure 5A illustrates the region where radiation dose to the breast skin was calculated adjacent to the compression plate.
Results Figure 6A shows the comparison of the 2D isodose curves, in the middle plane of the breast in XZ direction as shown in Figures 3A and 3B for HDR 192 Ir and 60 Co sources. These results are obtained by a 6 cm diameter standard and thick-walled applicator for a 6 cm thick compressed breast. The applicator wall thickness was increased from 6 mm to 12 mm for the HDR 60 Co source to attenuate the leakage radiation. Figure 6B indicates that the resultant dose distribution from HDR 60 Co source is similar to the HDR 192 Ir results. Similar results were obtained for the 4 cm and 8 cm thick compressions. These results indicate that dose distributions within the treatment volume are similar for HDR 192 Ir and 60 Co systems. In addition, these results were not very sensitive to the applicator wall thickness. Figure 7A shows a comparison of isodose curves, in the middle plane of a 6 cm thick compressed breast in the XZ direction, as shown in Figure 3C , using the standard applicator with a conical attenuator for the two radiation sources. Figure 7B chest wall for thick-wall applicator relative to the standard applicator. The influence of the applicator thickness on the chest wall is better shown in Figure 8 and Table 1 . This figure shows that for a 6 cm thick compressed breast and 6 cm diameter applicator, the area of the chest wall covered by a given dose by HDR 60 Co source is much smaller with thick-wall applicator than the standard applicator. The differences become smaller for larger doses as these isodose lines are covering the tissues that are located between the two applicators, hence the applicator thickness may not have much effect on them.
The maximum chest wall dose with the thick-wall applicator and HDR 60 Co source is 15 Gy (Figure 8A ) as compared to 5 Gy with HDR 192 Ir source and standard applicator. In addition Figure 8B shows the reduction of the chest wall dose using the cone attenuator in the applicator, for both source types. Similar results were obtained for the 4 cm and 8 cm thick compressed breast. As shown in Fig- ure 5B, the maximum chest wall area that was considered in these calculations was 900 cm 2 . Table 1 shows the tabulated data for the chest wall doses in the three different breast thicknesses, in the presence and absence of the attenuating cone. These results indicate that without the cone attenuator in the applicator for a 6 cm thick breast the 10 Gy isodose covers about 158.8 cm 2 and 26.3 cm 2 for the HDR 60 Co source with the standard and thick-wall applicator, respectively. Therefore, increasing the applicator wall thickness from 6 mm to 12 mm reduces the area of the chest wall covered by 10 Gy by about a factor of 6. Similar evaluation for results with the cone attenuator indicates a reduction factor of 7.5 for the area of the chest wall covered by 10 Gy, when the wall thickness is changed from 6 mm to 12 mm. A combination of wall thickness and attenuator reduces the skin dose from 158.8 cm 2 to 12 cm 2 (factor of 13). Figure 9 and Table 2 show the dose distribution to the breast skin that is calculated in a plane immediately after the compression plates, with and without the attenuating cone. These results are presented in terms of the breast skin area (cm 2 ) as a function of isodose values delivered with HDR 192 Ir and 60 Co sources, using the standard and thickwalled applicators. As shown in Figure 9 , increasing the applicator wall thickness from 6 mm to 12 mm reduces the skin dose significantly for doses below 20 Gy. However, the impact of the wall thickness is reduced for larger doses. In addition, for dose greater than 20 Gy, the differences of the skin dose for the two source types are less than 20%. For example, as shown in Table 2 , the breast skin areas covered by the 45 Gy isodose lines for the 6 cm thick compressed breast are 23.0 cm 2 , 24.4 cm 2 , and 24.6 cm 2 for the 192 Ir source in the standard applicator and the 60 Co source in standard and thick applicators, respectively.
Discussion
Feasibility of HDR 60 Co for the NIBB modality was evaluated in the current study. This evaluation was performed by comparing MC simulated dose distributions for an HDR 60 Co source in several breast geometries with those from the HDR 192 Ir system. Calculations were performed for the standard applicator and breast phantom geometries for both sources, and also with a thick-walled applicator for the HDR 60 Co to reduce the chest wall and skin doses. The simulations were performed for two commercially-available HDR sources; the microSelectron 192 Ir and the BEBIG 60 Co source as examples for these radionuclides. In these simulations, the 60 Co source strength was selected such that the dose to the midpoint of the breast would be identical to that of the 192 Ir source.
The results of these investigations show that the dose distributions within the treatment volume are nearly identical for HDR 192 Ir and 60 Co sources. In short, the Accu Boost paradigm for using HDR 192 Ir to deliver uniform central dose distributions and low skin doses held true HDR 60 Co using thick-walled applicators. These results are consistent with the reported data by Andrássy et al., which indicated that both radionuclides deliver similar dose distributions within the treatment volume [35] The results of these investigations have demonstrated that the impact of the applicator thickness was noticeable for the reduction of the skin doses below 20 Gy (Table 2 and Figure 9 ). However, for doses larger than 20 Gy, the thickness of the applicator does not have much effect on the skin dose. For example, for a 6 cm thick compressed breast, in absence of the attenuating cone, the skin area covered by the 15 Gy isodose line with the 60 Co source with standard and thick-walled applicators were 77.6 cm 2 and 58.1 cm 2 , respectively. This is a reduction of about 25%. The differences between the 60 Co source with the thick applicator and 192 Ir source with the standard applicator were decreased to within 10% at the 45 Gy isodose lines. Similar results were observed for different breast thicknesses. It should be noted that the skin doses presented herein were only for a two opposing fields. However, in an actual treatment, a 4-field technique or two sets of orthogonally oriented applicators would be used, which leads to a lower skin dose [38] .
Moreover, the influence of the applicator thickness on the chest wall dose was demonstrated in Table 1 and Figure 8 . These results show that, without the cone attenuator, the maximum chest wall dose with the thick-wall applicator and HDR 60 Co source is 10 Gy (Figure 8A ). This will reduce to 8 Gy with the use of cone attenuator.
Finally, the impact of a conical attenuator within the applicator on the dose distribution of different breast thicknesses for 60 Co was shown to be similar to that for the 192 Ir source. In addition, reductions of the chest wall and breast skin doses for 60 Co were similar as observed for the 192 Ir source.
Conclusions
In conclusion, HDR 60 Co brachytherapy appears to be a good alternative radionuclide to HDR 192 Ir brachytherapy as used for APBI treatments of breast cancer using the AccuBoost technique. In these treatments, the accumulated dose from 10 fractions in 5 days to the center of the breast would be 3400 cGy for each source type. Moreover, the actual treatments should be delivered in 10 fractions, as it is customary for 192 Ir source. The mechanism for applicator usage and clinical placement for irradiation with 60 Co should be similar to the currently used systems with 192 Ir sources [38] . It should be emphasized that the impact of the applicator weight and thickness on the assembly system of the treatment unit were beyond the scope of the current project. In the next step of this project, these issues will be evaluated prior to the clinical application of this system. Further, the elongated treatment time for the presently available 60 Co source models will also be evaluated.
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